Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Postprandial changes of lipoprotein profile: effect of abdominal obesity.

Sabaka P, Kruzliak P, Gaspar L, Caprnda M, Bendzala M, Balaz D, Oravec S, Dukat A.

Lipids Health Dis. 2013 Dec 8;12:179. doi: 10.1186/1476-511X-12-179.

2.

High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study.

Wojczynski MK, Glasser SP, Oberman A, Kabagambe EK, Hopkins PN, Tsai MY, Straka RJ, Ordovas JM, Arnett DK.

Lipids Health Dis. 2011 Oct 18;10:181. doi: 10.1186/1476-511X-10-181.

3.

Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women.

Magkos F, Mohammed BS, Mittendorfer B.

Int J Obes (Lond). 2008 Nov;32(11):1655-64. doi: 10.1038/ijo.2008.164. Epub 2008 Sep 9.

4.

Effect of short term aerobic exercise on fasting and postprandial lipoprotein subfractions in healthy sedentary men.

Sabaka P, Kruzliak P, Balaz D, Komornikova A, Celovska D, Cammarota G, Kusendova K, Bendzala M, Rodrigo L, Dukat A, Kwon TK, Dvorakova MC, Gaspar L.

Lipids Health Dis. 2015 Nov 25;14:151. doi: 10.1186/s12944-015-0148-5.

5.

Effect of sleeve gastrectomy on postprandial lipoprotein metabolism in morbidly obese patients.

Waldmann E, Hüttl TP, Göke B, Lang R, Parhofer KG.

Lipids Health Dis. 2013 Jun 1;12:82. doi: 10.1186/1476-511X-12-82.

7.

Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.

Tribble DL, Farnier M, Macdonell G, Perevozskaya I, Davies MJ, Gumbiner B, Musliner TA.

Metabolism. 2008 Jun;57(6):796-801. doi: 10.1016/j.metabol.2008.01.026.

PMID:
18502262
8.
9.

Circadian variation of postprandial lipemia.

Romon M, Le Fur C, Lebel P, Edmé JL, Fruchart JC, Dallongeville J.

Am J Clin Nutr. 1997 Apr;65(4):934-40.

PMID:
9094875
10.
11.

Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size.

Blackburn P, Côté M, Lamarche B, Couillard C, Pascot A, Tremblay A, Bergeron J, Lemieux I, Després JP.

Metabolism. 2003 Nov;52(11):1379-86.

PMID:
14624394
13.
14.
15.

Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women.

Furusyo N, Ai M, Okazaki M, Ikezaki H, Ihara T, Hayashi T, Hiramine S, Ura K, Kohzuma T, Schaefer EJ, Hayashi J.

Atherosclerosis. 2013 Dec;231(2):238-45. doi: 10.1016/j.atherosclerosis.2013.09.008. Epub 2013 Oct 1.

PMID:
24267234
16.

The influence of visceral fat on the postprandial lipemic response in men with paraplegia.

Emmons RR, Garber CE, Cirnigliaro CM, Moyer JM, Kirshblum SC, Galea MD, Spungen AM, Bauman WA.

J Am Coll Nutr. 2010 Oct;29(5):476-81.

PMID:
21504974
17.

Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.

Pirwany IR, Fleming R, Greer IA, Packard CJ, Sattar N.

Clin Endocrinol (Oxf). 2001 Apr;54(4):447-53.

PMID:
11318779
18.
19.

Lipoprotein subclass abnormalities and incident hypertension in initially healthy women.

Paynter NP, Sesso HD, Conen D, Otvos JD, Mora S.

Clin Chem. 2011 Aug;57(8):1178-87. doi: 10.1373/clinchem.2011.167544. Epub 2011 Jun 23.

20.

Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.

Robinson JG, Ballantyne CM, Hsueh WA, Rosen JB, Lin J, Shah AK, Tomassini JE, Lowe RS, Tershakovec AM.

J Clin Lipidol. 2013 Jul-Aug;7(4):292-303. doi: 10.1016/j.jacl.2013.03.007. Epub 2013 Apr 3.

PMID:
23890516

Supplemental Content

Support Center